Rosenblum Silverman Sutton’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Sell |
|
|||||
|
2025
Q1 | $9.35M | Sell |
|
|||||
|
2024
Q4 | $8.18M | Sell |
|
|||||
|
2024
Q3 | $9.67M | Sell |
|
|||||
|
2024
Q2 | $8.55M | Sell |
|
|||||
|
2024
Q1 | $5.3M | Sell |
|
|||||
|
2023
Q4 | $6.88M | Sell |
|
|||||
|
2023
Q3 | $6.56M | Sell |
|
|||||
|
2023
Q2 | $7.06M | Sell |
|
|||||
|
2023
Q1 | $7.52M | Sell |
|
|||||
|
2022
Q4 | $9.48M | Sell |
|
|||||
|
2022
Q3 | $8.03M | Sell |
|
|||||
|
2022
Q2 | $6.21M | Buy |
|
|||||
|
2022
Q1 | $6.82M | Sell |
|
|||||
|
2021
Q4 | $7.18M | Sell |
|
|||||
|
2021
Q3 | $8.12M | Sell |
|
|||||
|
2021
Q2 | $7.36M | Buy |
|
|||||
|
2021
Q1 | $6.06M | Buy |
|
|||||
|
2020
Q4 | $5.47M | Buy |
|
|||||
|
2020
Q3 | $6.09M | Buy |
|
|||||
|
2020
Q2 | $5.78M | Buy |
|
|||||
|
2020
Q1 | $4.1M | Buy |
|